Uxin Ltd Files 6-K with Financials
Ticker: UXIN · Form: 6-K · Filed: Oct 14, 2025 · CIK: 1729173
| Field | Detail |
|---|---|
| Company | Uxin Ltd (UXIN) |
| Form Type | 6-K |
| Filed Date | Oct 14, 2025 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: financials, sec-filing, 6-K
TL;DR
Uxin Ltd dropped its Q2 2025 financials on 10/14/25 via a 6-K filing.
AI Summary
Uxin Limited filed a Form 6-K on October 14, 2025, reporting its unaudited interim condensed consolidated financial statements for the period ending June 30, 2025. The filing includes financial statements as Exhibit 99.1 and management's discussion and analysis as Exhibit 99.2.
Why It Matters
This filing provides investors with updated financial information for Uxin Ltd, allowing them to assess the company's performance and financial health.
Risk Assessment
Risk Level: low — This is a routine financial filing and does not contain new material information that would inherently increase risk.
Key Numbers
- 6-K — Filing Type (Report of Foreign Private Issuer)
Key Players & Entities
- Uxin Limited (company) — Registrant
- 001-38527 (company) — Commission File Number
- 20251014 (date) — Filing Date
- 20250630 (date) — Period of Report
FAQ
What is the primary purpose of this Form 6-K filing?
The primary purpose of this Form 6-K filing is to report the unaudited interim condensed consolidated financial statements and management's discussion and analysis for Uxin Limited.
What period do the financial statements in this filing cover?
The financial statements in this filing cover the period ending June 30, 2025.
When was this Form 6-K filed with the SEC?
This Form 6-K was filed with the SEC on October 14, 2025.
What are the exhibit numbers for the financial statements and management's discussion?
The unaudited interim condensed consolidated financial statements are Exhibit 99.1, and management's discussion and analysis is Exhibit 99.2.
What is Uxin Limited's principal executive office address?
Uxin Limited's principal executive office is located at 21/F, Donghuang Building, No.16 Guangshun South Avenue, Chaoyang District, Beijing 100102, People's Republic of China.
Filing Stats: 159 words · 1 min read · ~1 pages · Grade level 12.5 · Accepted 2025-10-14 06:17:24
Filing Documents
- form6-k.htm (6-K) — 22KB
- ex99-1.htm (EX-99.1) — 1572KB
- ex99-2.htm (EX-99.2) — 241KB
- 0001493152-25-017885.txt ( ) — 9533KB
- uxin-20250630.xsd (EX-101.SCH) — 70KB
- uxin-20250630_cal.xml (EX-101.CAL) — 94KB
- uxin-20250630_def.xml (EX-101.DEF) — 266KB
- uxin-20250630_lab.xml (EX-101.LAB) — 500KB
- uxin-20250630_pre.xml (EX-101.PRE) — 403KB
- form6-k_htm.xml (XML) — 1857KB
Management's Discussion and Analysis of Financial Condition and Results of Operations
Management's Discussion and Analysis of Financial Condition and Results of Operations
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. UXIN LIMITED By: /s/ Feng Lin Name: Feng Lin Title: Chief Financial Officer Date: October 14, 2025